TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
GHN Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
180
|
27
|
598 |
Financial expenses |
1
|
219
|
31 |
Earnings before taxes |
477
|
-267
|
1,503 |
EBITDA |
-5
|
-181
|
-151 |
Total assets |
8,611
|
8,143
|
9,245 |
Current assets |
268
|
216
|
331 |
Current liabilities |
76
|
19
|
33 |
Equity capital |
8,535
|
8,124
|
9,211 |
- share capital |
37
![]() |
37
|
40 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
99.1%
|
99.8%
|
99.6% |
Turnover per employee |
90
|
14
|
299 |
Profit as a percentage of turnover |
265.0%
|
-988.9%
|
251.3% |
Return on assets (ROA) |
5.6%
|
-0.6%
|
16.6% |
Current ratio |
352.6%
|
1136.8%
|
1003.0% |
Return on equity (ROE) |
5.6%
|
-3.3%
|
16.3% |
Change turnover |
153
|
-523
|
590 |
Change turnover % |
575%
|
-95%
|
7448% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.